SER co-owners Javier Candon and Christiana Campos commemorated 10 years at 1110 N. Glebe Road over the weekend alongside about 300 supporters. Expressing gratitude for community support and ...

ROURKELA: Aggressive posturing of the South Eastern Railway (SER) to remove mass encroachment from its Bondamunda colony and adjacent land has created panic among the illegal residents with ...

the company’s potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of epidermal growth factor receptor (EGFR)-expressing solid tumors. Based on this clearance, ALX ...

ALX2004 is a potential best- and first-in-class antibody-drug conjugate (ADC) for the treatment of EGFR-expressing solid tumors that was created from ALX Oncology’s proprietary linker-payload platform ...

Italian online store Zanetti lists various S25 Edge devices – the 256GB version is €1,362, while the 512GB option is €1,488. This is higher than the initially expected prices for Europe ...

The US Supreme Court has cleared the way for President Donald Trump to use a rarely-invoked wartime powers law to rapidly deport alleged gang members - for now. A lower court had temporarily ...

1Department of Pathology, Yale University School of Medicine, New Haven, Connecticut. 2Department of Internal Medicine, National and Kapodistrian University of Athens, School of Medicine, Sotiria ...

ALY-101 is designed for local and selective modulation of inflammation and targets JAK1, a key driver of alopecia areata, with a JAK1-targeting siRNA-lipid conjugate. For the initial indication, it is ...

State Key Laboratory of Drug Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 501 Haike Road, Shanghai 201203, China State Key Laboratory of Drug Research, Shanghai ...

Department of Organic Materials Science, Graduate School of Organic Materials Science, Yamagata University, 4-3-16 Jonan, Yonezawa, Yamagata 990-0021, Japan ...

CHENGDU, China I March 25, 2025 I Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. (the “Company”) announced that the Company has received a clinical trial notice approving the investigational new ...